 In Vitro Toxicology Testing Market Insights, Competitive Landscape, and Market Forecast - 2033
In vitro toxicology testing is gaining ground rapidly as industries and regulators seek safer, faster, and more ethical alternatives to animal studies. Progress in cell-based assays, automated scre... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryIn vitro toxicology testing is gaining ground rapidly as industries and regulators seek safer, faster, and more ethical alternatives to animal studies. Progress in cell-based assays, automated screening, and organ-on-chip platforms is making non-animal methods more predictive, encouraging pharmaceutical, chemical, and cosmetics companies to expand their use of these approaches for safety assessment. The global in vitro toxicology testing market is expected to be valued at US$ 8.60 Billion in 2026 and is projected to reach US$ 16.03 Billion by 2033, growing at a CAGR of 9.3% between 2026 and 2033.Market Insights: This market encompasses laboratory methods that assess toxicity using cultured cells, engineered tissues, and automated platforms. Technologies include cell culture-based assays, high-throughput screening, organ-on-chip technology, and other approaches. Applications span pharmaceuticals and biotech, cosmetics and personal care, chemicals, and others, with pharmaceutical and biotech use generating the most revenue and cosmetics and personal care expanding the fastest. End users include drug developers, contract research organizations, and cosmetics and chemical firms. Ongoing improvements in the predictive accuracy and biological relevance of in vitro models are strengthening their role in regulatory submissions and development decisions. Drivers: Growth is closely tied to intensifying regulatory and industry emphasis on reducing animal testing, with authorities increasingly accepting or mandating alternative methods and companies adopting public commitments to limit animal use. At the same time, continued technology advancement is improving the predictive accuracy and biological relevance of in vitro models, making them more reliable tools for safety assessment. The high cost of drug candidates failing late in development due to toxicity encourages earlier and broader screening. Rising research investment and the need for faster turnaround times further support demand across pharmaceutical, chemical, and consumer product sectors. Business Opportunity: Adoption in the cosmetics and personal care sector offers a significant growth opportunity, as bans on animal testing for cosmetics in a growing number of jurisdictions have made in vitro toxicology testing essential for product safety assessment. Providers with validated skin irritation, eye irritation, and sensitization models stand to gain considerably. Organ-on-chip and three-dimensional tissue technologies offer further potential by generating more human-relevant results. Contract research organizations can broaden their testing services, while computational toxicology and integrated data platforms provide additional avenues to improve predictive power and shorten safety evaluation timelines. Region Analysis: North America leads the global in vitro toxicology testing market with a 40.0% share in 2026, reflecting large pharmaceutical research budgets, sophisticated laboratory capabilities, and regulatory support for alternative testing methods. Europe represents approximately 32.0%, supported by strict animal testing restrictions, especially for cosmetic products. Asia Pacific holds about 20.0% and is projected to be the fastest-growing region, driven by increasing regulatory alignment with international testing standards and rapid growth in pharmaceutical development and contract research. Latin America accounts for around 5.0% and Middle East & Africa about 3.0%, with adoption gradually rising as regulatory frameworks mature. Key Players: • Charles River Laboratories International, Inc. • Merck KGaA • Thermo Fisher Scientific Inc. • Eurofins Scientific SE • Bio-Rad Laboratories, Inc. • Catalent, Inc. • SGS SA • Evotec SE • MatTek Life Sciences • Reprocell Inc. Segmentation: By Technology • Cell Culture-Based Assays • High-Throughput Screening • Organ-on-Chip Technology • Others By Application • Pharmaceutical & Biotech • Cosmetics & Personal Care • Chemicals • Others By End User • Pharmaceutical & Biotech Companies • Contract Research Organizations • Cosmetics & Chemical Companies By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa Table of Contents1. Executive Summary1.1. Global In Vitro Toxicology Testing Market Snapshot 1.2. Future Projections 1.3. Key Market Trends 1.4. Regional Snapshot, by Value, 2026 1.5. Analyst Recommendations 2. Market Overview 2.1. Market Definitions and Segmentations 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Market Opportunities 2.3. Value Chain Analysis 2.4. COVID-19 Impact Analysis 2.5. Porter's Five Forces Analysis 2.6. Impact of Russia-Ukraine Conflict 2.7. PESTLE Analysis 2.8. Regulatory Analysis 2.9. Price Trend Analysis 2.9.1. Current Prices and Future Projections, 2025-2033 2.9.2. Price Impact Factors 3. Global In Vitro Toxicology Testing Market Outlook, 2020-2033 3.1. Global In Vitro Toxicology Testing Market Outlook, by Technology, Value (US$ Bn), 2020-2033 3.1.1. Cell Culture-Based Assays 3.1.2. High-Throughput Screening 3.1.3. Organ-on-Chip Technology 3.1.4. Others 3.2. Global In Vitro Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033 3.2.1. Pharmaceutical & Biotech 3.2.2. Cosmetics & Personal Care 3.2.3. Chemicals 3.2.4. Others 3.3. Global In Vitro Toxicology Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033 3.3.1. Pharmaceutical & Biotech Companies 3.3.2. Contract Research Organizations 3.3.3. Cosmetics & Chemical Companies 3.4. Global In Vitro Toxicology Testing Market Outlook, by Region, Value (US$ Bn), 2020-2033 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Latin America 3.4.5. Middle East & Africa 4. North America In Vitro Toxicology Testing Market Outlook, 2020-2033 4.1. North America In Vitro Toxicology Testing Market Outlook, by Technology, Value (US$ Bn), 2020-2033 4.1.1. Cell Culture-Based Assays 4.1.2. High-Throughput Screening 4.1.3. Organ-on-Chip Technology 4.1.4. Others 4.2. North America In Vitro Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033 4.2.1. Pharmaceutical & Biotech 4.2.2. Cosmetics & Personal Care 4.2.3. Chemicals 4.2.4. Others 4.3. North America In Vitro Toxicology Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033 4.3.1. Pharmaceutical & Biotech Companies 4.3.2. Contract Research Organizations 4.3.3. Cosmetics & Chemical Companies 4.4. North America In Vitro Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033 4.4.1. U.S. In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 4.4.2. U.S. In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 4.4.3. U.S. In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 4.4.4. Canada In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 4.4.5. Canada In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 4.4.6. Canada In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 4.5. BPS Analysis/Market Attractiveness Analysis 5. Europe In Vitro Toxicology Testing Market Outlook, 2020-2033 5.1. Europe In Vitro Toxicology Testing Market Outlook, by Technology, Value (US$ Bn), 2020-2033 5.1.1. Cell Culture-Based Assays 5.1.2. High-Throughput Screening 5.1.3. Organ-on-Chip Technology 5.1.4. Others 5.2. Europe In Vitro Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033 5.2.1. Pharmaceutical & Biotech 5.2.2. Cosmetics & Personal Care 5.2.3. Chemicals 5.2.4. Others 5.3. Europe In Vitro Toxicology Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033 5.3.1. Pharmaceutical & Biotech Companies 5.3.2. Contract Research Organizations 5.3.3. Cosmetics & Chemical Companies 5.4. Europe In Vitro Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033 5.4.1. Germany In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 5.4.2. Germany In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 5.4.3. Germany In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 5.4.4. Italy In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 5.4.5. Italy In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 5.4.6. Italy In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 5.4.7. France In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 5.4.8. France In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 5.4.9. France In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 5.4.10. U.K. In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 5.4.11. U.K. In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 5.4.12. U.K. In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 5.4.13. Spain In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 5.4.14. Spain In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 5.4.15. Spain In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 5.4.16. Russia In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 5.4.17. Russia In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 5.4.18. Russia In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 5.4.19. Rest of Europe In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 5.4.20. Rest of Europe In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 5.4.21. Rest of Europe In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 5.5. BPS Analysis/Market Attractiveness Analysis 6. Asia Pacific In Vitro Toxicology Testing Market Outlook, 2020-2033 6.1. Asia Pacific In Vitro Toxicology Testing Market Outlook, by Technology, Value (US$ Bn), 2020-2033 6.1.1. Cell Culture-Based Assays 6.1.2. High-Throughput Screening 6.1.3. Organ-on-Chip Technology 6.1.4. Others 6.2. Asia Pacific In Vitro Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033 6.2.1. Pharmaceutical & Biotech 6.2.2. Cosmetics & Personal Care 6.2.3. Chemicals 6.2.4. Others 6.3. Asia Pacific In Vitro Toxicology Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033 6.3.1. Pharmaceutical & Biotech Companies 6.3.2. Contract Research Organizations 6.3.3. Cosmetics & Chemical Companies 6.4. Asia Pacific In Vitro Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033 6.4.1. China In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 6.4.2. China In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 6.4.3. China In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 6.4.4. Japan In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 6.4.5. Japan In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 6.4.6. Japan In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 6.4.7. South Korea In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 6.4.8. South Korea In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 6.4.9. South Korea In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 6.4.10. India In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 6.4.11. India In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 6.4.12. India In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 6.4.13. Southeast Asia In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 6.4.14. Southeast Asia In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 6.4.15. Southeast Asia In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 6.4.16. Rest of SAO In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 6.4.17. Rest of SAO In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 6.4.18. Rest of SAO In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 6.5. BPS Analysis/Market Attractiveness Analysis 7. Latin America In Vitro Toxicology Testing Market Outlook, 2020-2033 7.1. Latin America In Vitro Toxicology Testing Market Outlook, by Technology, Value (US$ Bn), 2020-2033 7.1.1. Cell Culture-Based Assays 7.1.2. High-Throughput Screening 7.1.3. Organ-on-Chip Technology 7.1.4. Others 7.2. Latin America In Vitro Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033 7.2.1. Pharmaceutical & Biotech 7.2.2. Cosmetics & Personal Care 7.2.3. Chemicals 7.2.4. Others 7.3. Latin America In Vitro Toxicology Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033 7.3.1. Pharmaceutical & Biotech Companies 7.3.2. Contract Research Organizations 7.3.3. Cosmetics & Chemical Companies 7.4. Latin America In Vitro Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033 7.4.1. Brazil In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 7.4.2. Brazil In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 7.4.3. Brazil In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 7.4.4. Mexico In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 7.4.5. Mexico In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 7.4.6. Mexico In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 7.4.7. Argentina In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 7.4.8. Argentina In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 7.4.9. Argentina In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 7.4.10. Rest of LATAM In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 7.4.11. Rest of LATAM In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 7.4.12. Rest of LATAM In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 7.5. BPS Analysis/Market Attractiveness Analysis 8. Middle East & Africa In Vitro Toxicology Testing Market Outlook, 2020-2033 8.1. Middle East & Africa In Vitro Toxicology Testing Market Outlook, by Technology, Value (US$ Bn), 2020-2033 8.1.1. Cell Culture-Based Assays 8.1.2. High-Throughput Screening 8.1.3. Organ-on-Chip Technology 8.1.4. Others 8.2. Middle East & Africa In Vitro Toxicology Testing Market Outlook, by Application, Value (US$ Bn), 2020-2033 8.2.1. Pharmaceutical & Biotech 8.2.2. Cosmetics & Personal Care 8.2.3. Chemicals 8.2.4. Others 8.3. Middle East & Africa In Vitro Toxicology Testing Market Outlook, by End User, Value (US$ Bn), 2020-2033 8.3.1. Pharmaceutical & Biotech Companies 8.3.2. Contract Research Organizations 8.3.3. Cosmetics & Chemical Companies 8.4. Middle East & Africa In Vitro Toxicology Testing Market Outlook, by Country, Value (US$ Bn), 2020-2033 8.4.1. GCC In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 8.4.2. GCC In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 8.4.3. GCC In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 8.4.4. South Africa In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 8.4.5. South Africa In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 8.4.6. South Africa In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 8.4.7. Egypt In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 8.4.8. Egypt In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 8.4.9. Egypt In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 8.4.10. Nigeria In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 8.4.11. Nigeria In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 8.4.12. Nigeria In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 8.4.13. Rest of Middle East In Vitro Toxicology Testing Market Outlook, by Technology, 2020-2033 8.4.14. Rest of Middle East In Vitro Toxicology Testing Market Outlook, by Application, 2020-2033 8.4.15. Rest of Middle East In Vitro Toxicology Testing Market Outlook, by End User, 2020-2033 8.5. BPS Analysis/Market Attractiveness Analysis 9. Competitive Landscape 9.1. Company Vs Segment Heatmap 9.2. Company Market Share Analysis, 2025 9.3. Competitive Dashboard 9.4. Company Profiles 9.4.1. Charles River Laboratories International, Inc. 9.4.1.1. Company Overview 9.4.1.2. Product Portfolio 9.4.1.3. Financial Overview 9.4.1.4. Business Strategies and Developments 9.4.2. Merck KGaA 9.4.3. Thermo Fisher Scientific Inc. 9.4.4. Eurofins Scientific SE 9.4.5. Bio-Rad Laboratories, Inc. 9.4.6. Catalent, Inc. 9.4.7. SGS SA 9.4.8. Evotec SE 9.4.9. MatTek Life Sciences 9.4.10. Reprocell Inc. 10. Appendix 10.1. Research Methodology 10.2. Report Assumptions 10.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療IT）の最新刊レポート
Fairfield Market Research社の ヘルスケアIT分野 での最新刊レポート
本レポートと同じKEY WORD（landscape）の最新刊レポート
よくあるご質問Fairfield Market Research社はどのような調査会社ですか?Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
